Category: Company

Amgen And Humana Partner For Improved Health Outcomes And Efficiency

THOUSAND OAKS, Calif. and LOUISVILLE, Ky., Aug. 17, 2017 /PRNewswire/ — Two of the nation’s leading health organizations, health and well-being company Humana Inc. (NYSE: HUM) and biotechnology company Amgen (NASDAQ:AMGN), have teamed up to identify opportunities to improve health… http://www.prnewswire.com/news-releases/amgen-and-humana-partner-for-improved-health-outcomes-and-efficiency-300506215.html

Pfizer spinoff Zoetis ups 2017 guidance, eyes more M&A for future growth

What does Pfizer animal health spinoff Zoetis share with its former parent, aside from its lineage? They’re both under pressure from investors to drive growth through acquisitions. Zoetis met second-quarter expectations and brightened its forecast for the rest of the year, and now it’s looking to M&A to drive further growth. http://www.fiercepharma.com/financials/pfizer-spinoff-zoetis-ups-2017-guidance-eyes-m-a-for-future-growth

Lilly puts two-thirds of mid-phase cancer pipeline up for sale in major shake up of R&D priorities

Eli Lilly is seeking partners for two-thirds of its mid-phase oncology compounds. The Big Pharma wants to offload six phase 2 candidates to focus its R&D dollars on a clutch of early to mid-stage assets it thinks can become the new standard of care. http://www.fiercebiotech.com/biotech/lilly-puts-two-thirds-mid-phase-cancer-pipeline-up-for-sale-major-shake-up-r-d-priorities